The 10-second takeaway
For the quarter ended March 31 (Q1), Omega Protein beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. Non-GAAP earnings per share expanded significantly. GAAP earnings per share expanded significantly.
Margins grew across the board.
Omega Protein notched revenue of $48.9 million. The two analysts polled by S&P Capital IQ expected to see a top line of $41.8 million on the same basis. GAAP reported sales were 23% higher than the prior-year quarter's $39.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.15. The three earnings estimates compiled by S&P Capital IQ predicted $0.09 per share. Non-GAAP EPS of $0.15 for Q1 were 88% higher than the prior-year quarter's $0.08 per share. GAAP EPS of $0.14 for Q1 were 56% higher than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 24.7%, 230 basis points better than the prior-year quarter. Operating margin was 10.4%, 340 basis points better than the prior-year quarter. Net margin was 5.8%, 120 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $48.7 million. On the bottom line, the average EPS estimate is $0.13.
Next year's average estimate for revenue is $255.7 million. The average EPS estimate is $0.79.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 120 members out of 132 rating the stock outperform, and 12 members rating it underperform. Among 33 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give Omega Protein a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omega Protein is buy, with an average price target of $12.00.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Omega Protein to My Watchlist.